Innospec Secures China Approval for Its Flagship Ultra-Mild, Sulfate-Free Iselux® Surfactants
05 Janvier 2022 - 2:00PM
Innospec today announces that Iselux® [INCI: Sodium Lauroyl Methyl
Isethionate], its industry-leading, sulfate and 1,4-dioxane free
surfactant technology, has been approved for use in China, the
world’s second largest personal care market.
Available in liquid and solid form, Iselux® is a
highly versatile, clear, mild and natural surfactant which delivers
superior lather, skin feel and cleansing performance in more than
3,000 body, hair and other personal care products
today. With the China approval secured, for the first
time Iselux® is now available for worldwide cosmetic and personal
care use by Innospec’s customers.
Innospec technologies like
Iselux® directly address growing long-term
consumer demand for clean beauty without any compromise in product
performance. Innospec recently announced plans for over $70MM of
organic growth investments to be made through 2023 to support the
increased demand outlook for its premium personal and home care
technologies.
Bruce McDonald, President of Innospec
Performance Chemicals, said,
“This approval not only opens the door for
Iselux® sales for the first time in China, but also substantially
expands the breadth of premium formulation alternatives that we can
offer our customers in this important market. Furthermore, this
approval gives our customers the option to standardize their global
formulations and simplify their supply-chains around an Iselux®
chassis in all geographies.”
Patrick S. Williams, President and Chief
Executive Officer of Innospec, added,
“Our team has worked diligently with China’s
regulators over many years to gain this important approval. I am
excited by the enhanced formulation and supply-chain options that
this global approval gives to our customers. Innospec is well
positioned to support our customers’ sustainability goals through
continued investment in our innovative, clean beauty
technologies.”
About Innospec Inc.
Innospec Inc. is an international specialty
chemicals company with approximately 1,900 employees in 23
countries. Innospec manufactures and supplies a wide range of
specialty chemicals to markets in the Americas, Europe, the Middle
East, Africa and Asia-Pacific. The Fuel Specialties business
specializes in manufacturing and supplying fuel additives that
improve fuel efficiency, boost engine performance and reduce
harmful emissions. Oilfield Services provides specialty chemicals
to all elements of the oil and gas exploration and production
industry. The Performance Chemicals business creates
innovative technology-based solutions for our customers in the
Personal Care, Home Care, Agrochemical, Mining and Industrial
markets. Octane Additives produces octane improvers to enhance
gasoline.
Forward-Looking Statements
This press release contains certain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
other than statements of historical facts included or incorporated
herein may constitute forward-looking statements. Such
forward-looking statements include statements (covered by words
like “expects,” “estimates,” “anticipates,” “may,” “believes,”
“feels,” “plan,” “intend” or similar words or expressions, for
example) which relate to earnings, growth potential, operating
performance, events or developments that we expect or anticipate
will or may occur in the future. Although forward-looking
statements are believed by management to be reasonable when made,
they are subject to certain risks, uncertainties and assumptions,
including, the effects of the COVID-19 pandemic, such as its
duration, its unknown long-term economic impact, measures taken by
governmental authorities to address it and the manner in which the
pandemic may precipitate or exacerbate other risks and/or
uncertainties, and our actual performance or results may differ
materially from these forward-looking statements. Additional
information regarding risks, uncertainties and assumptions relating
to Innospec and affecting our business operations and prospects are
described in Innospec’s Annual Report on Form 10-K for the year
ended December 31, 2020, Innospec’s Quarterly Report on Form 10-Q
for the quarter ended September 30, 2021 and other reports filed
with the U.S. Securities and Exchange Commission. You are
urged to review our discussion of risks and uncertainties that
could cause actual results to differ from forward-looking
statements under the heading "Risk Factors” in such reports.
Innospec undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contacts:
Corbin BarnesInnospec
Inc.+44-151-355-3611corbin.barnes@innospecinc.com
Innospec (NASDAQ:IOSP)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Innospec (NASDAQ:IOSP)
Graphique Historique de l'Action
De Août 2023 à Août 2024